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Abstract
We investigated the antitumor effect of purified natural human tumor necrosis factor-beta
(nHuTNF-beta) produced by human acute lymphoblastic leukemia BALL-1 cells stimulated with
HVJ on pulmonary metastatic tumors of Lewis lung carcinoma (3LL) transplanted into BDF1
mice. nHuTNF-beta showed antiproliferative effects on metastatic tumors in a dose-dependent
manner when administered daily for 10 days by the intravenous route. Histological examination of
the tumors treated with nHuTNF-beta revealed that the tumor size and number of metastases were
much reduced. Lytic cellular changes, including cytoplasmic vacuolation, loosening of the inter-
cellular junction and both cytoplasmic and nuclear swelling, were found, but tumor necrosis was
not. These findings indicate a therapeutic effect of Grade IIa according to the histological criteria
of Shimosato and Ohboshi. In addition, synergistic augmentation of the antiproliferative effects
of nHuTNF-beta by natural murine interferon-alpha/beta (nMu-IFN-alpha/beta) or recombinant
murine interferon-gamma (rMuIFN-gamma) was recognized by median effect plot analysis. The
results suggested that nHuTNF-beta may well deserve clinical trial as a new immunotherapeutical
agent for human cancer.
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